Efficacy of Oxepa Enteral Feeding in LTAC (Long Term Acute Care Hospital) Patients on Chronic Ventilation- a Pilot Study



Status:Recruiting
Conditions:Hospital, Hospital, Pulmonary
Therapuetic Areas:Pulmonary / Respiratory Diseases, Other
Healthy:No
Age Range:19 - Any
Updated:4/2/2016
Start Date:January 2014

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Efficacy of the Use of Enteral Feeding High in EPA,GLA and Antioxidants in LTAC Patients on Chronic Ventilation- a Pilot Study

Patients with mechanical ventilation have shown improved weaning rates when enteral tube
feeding high in EPA, GLA and antioxidants were fed to patients in the critical care setting.

LTAC Patients on chronic mechanical ventilation will have decreased days an mechanical
ventilation, decreased mortality rates and decreased organ failure when fed an enteral
product high in EPA, GLA and antioxidants compared to an isotonic high fiber enteral
nutrition product.


Inclusion Criteria:

>18 years old with Respiratory failure on mechanical ventilation with failure to wean
Diagnosis of ARDS (Acute respiratory Distress Syndrome) Bilateral infiltrates -

Exclusion Criteria:

History Of pulmonary fibrosis, Terminal illness/ malignancies, <28 day life expectancy,
Hemodialysis, Active bleeding or bleeding disorder: DIC ( Disseminated intravascular
Coagulation), Sickle Cell Anemia, Hemophilia Hemorrhagic or ischemic stroke, Liver
failure, Head trauma with Glasgow coma scale score of <5, Immunosuppression: WBC(White
Blood Cell Count) <5000, HIV positive, use of immunosuppressant drugs, Pregnancy, and
Heart Failure with EF(Ejection Fraction) <35%
We found this trial at
1
site
Grace Hospital
Cleveland, Ohio 44111
?
mi
from
Cleveland, OH
Click here to add this to my saved trials